PALMIGO

PALMIGO

The PALMIGO capsule is a breakthrough in the management of neuropathic pain and chronic pain and is an innovative, synergistic, and safer alternative to conventional therapy. PALMIGO contains Palmitoylethanolamide (PEA) 300mg, Genistein 4 mg, and Daidzein 30mg; all the ingredients are taken from biological sources.

PALMIGO activates the nuclear receptor Peroxisome Proliferator-Activated Receptor alpha (PPAR-α). Activation of the PPAR-α receptor initiates a cascade of events that causes the suppression of pro-inflammatory cytokines such as IL-1β and 6, and TNF-α, resulting in a reduction in pain and inflammation. PALMIGO is indicated for neuropathic pain, diabetic neuropathy, sciatic pain, nerve compression pain, fibromyalgia, and chronic pain.

The dosage of PALMIGO is 1-2 capsules, preferably divided over the day or as prescribed by a medical practitioner.